1. Home
  2. RENB vs OVID Comparison

RENB vs OVID Comparison

Compare RENB & OVID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RENB
  • OVID
  • Stock Information
  • Founded
  • RENB 2011
  • OVID 2014
  • Country
  • RENB United States
  • OVID United States
  • Employees
  • RENB N/A
  • OVID N/A
  • Industry
  • RENB Biotechnology: Pharmaceutical Preparations
  • OVID Biotechnology: Pharmaceutical Preparations
  • Sector
  • RENB Health Care
  • OVID Health Care
  • Exchange
  • RENB Nasdaq
  • OVID Nasdaq
  • Market Cap
  • RENB 62.0M
  • OVID 20.6M
  • IPO Year
  • RENB N/A
  • OVID 2017
  • Fundamental
  • Price
  • RENB $0.29
  • OVID $0.34
  • Analyst Decision
  • RENB
  • OVID Strong Buy
  • Analyst Count
  • RENB 0
  • OVID 4
  • Target Price
  • RENB N/A
  • OVID $3.13
  • AVG Volume (30 Days)
  • RENB 4.2M
  • OVID 1.6M
  • Earning Date
  • RENB 05-15-2025
  • OVID 08-12-2025
  • Dividend Yield
  • RENB N/A
  • OVID N/A
  • EPS Growth
  • RENB N/A
  • OVID N/A
  • EPS
  • RENB N/A
  • OVID N/A
  • Revenue
  • RENB N/A
  • OVID $548,000.00
  • Revenue This Year
  • RENB N/A
  • OVID N/A
  • Revenue Next Year
  • RENB N/A
  • OVID $5.32
  • P/E Ratio
  • RENB N/A
  • OVID N/A
  • Revenue Growth
  • RENB N/A
  • OVID 15.61
  • 52 Week Low
  • RENB $0.27
  • OVID $0.24
  • 52 Week High
  • RENB $2.10
  • OVID $1.47
  • Technical
  • Relative Strength Index (RSI)
  • RENB 40.92
  • OVID 56.68
  • Support Level
  • RENB $0.33
  • OVID $0.30
  • Resistance Level
  • RENB $0.37
  • OVID $0.33
  • Average True Range (ATR)
  • RENB 0.04
  • OVID 0.03
  • MACD
  • RENB -0.01
  • OVID 0.00
  • Stochastic Oscillator
  • RENB 14.96
  • OVID 84.62

About RENB Renovaro Biosciences Inc.

Renovaro Inc is a biopharmaceutical company. It is engaged in developing new immunotherapies to combat cancer and developing a predicative artificial intelligence-based diagnostic methodology for the use of earlier cancer detection.

About OVID Ovid Therapeutics Inc.

Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.

Share on Social Networks: